Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis: Real-life data from the biologic Apulian registry (BIOPURE)
Clinical Rheumatology Feb 11, 2018
Iannone F, et al. - Researchers intended to scrutinize the drug survival and effectiveness of ustekinumab in psoriatic arthritis (PsA) patients naive to biologics or inadequate responders to tumor necrosis factor (TNF-IR) inhibitors in real life setting. A good effectiveness of ustekinumab was illustrated in real life. Biologic-naïve PsA patients reported best outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
